Skip Navigation

Vaccine Safety Bibliography - May 2011

1.   Measles outbreaks and progress towards meeting measles pre-elimination goals:  WHO African Region,2009-2010. Wkly Epidemiol Rec. 2011 Apr 1; 86(14):129-36.

2.   Meningitis in Burkina Faso, Chad, Niger, Nigeria and Ghana: 2010 epidemic season. Wkly Epidemiol Rec. 2011 Apr 8; 86(15):143-51.

3.   Monitoring progress towards global polio eradication: poliovirus surveillance, 2009-2010. Wkly Epidemiol Rec. 2011 Apr 15; 86(16):153-60.

4.   Recommendations for institutional prematriculation immunizations. J Am Coll Health. 2011 Apr; 59(5):450-8.

5.   Advani A, Gustafsson L, Ahrén C, Mooi FR, Hallander HO. Appearance of Fim3 and ptxP3-Bordetella pertussis strains, in two regions of Sweden with different vaccination programs. Vaccine. 2011 Apr 18; 29(18):3438-42.

6.   Agnandji ST, Fendel R, Mestré M, Janssens M, Vekemans J, Held J, Gnansounou F, Haertle S, von Glasenapp I, Oyakhirome S, Mewono L, Moris P, Lievens M, Demoitie MA, Dubois PM, Villafana T, Jongert E, Olivier A, Cohen J, Esen M, Kremsner PG, Lell B, Mordmüller B. Induction of Plasmodium falciparum-Specific CD4 T Cells and Memory B Cells in Gabonese Children Vaccinated with RTS,S/AS01(E) and RTS, S/AS02 (D). PLoS One. 2011 Apr 11; 6(4):e18559.

7.   Ahmad R, Alvi SS, Hassan M, Kamin M, Malik M, Sarwar L, Sohail H, Wahab H, Zafar M, Iqbal S. Availability of expanded programme of immunization services provided to children in a rural Pakistani village. J Pak Med Assoc. 2011 Apr; 61(4):415-8.

8.   Akin L, Kaya M, Altinel S, Durand L. Cost of pneumococcal infections and cost-effectiveness analysis of pneumococcal vaccination at risk adults and elderly in Turkey. Hum Vaccin. 2011 Apr 1; 7(4). [Epub ahead of print].

9.   Al-Hassan AA, Ahsanullah AM. Bacillus Calmette-Guerins vaccination at birth causing tuberculous granulomatous lymphadenitis. Saudi Med J. 2011 Apr; 32(4):412-4.

10.  Alecsandru D, Valor L, Sánchez-Ramón S, Gil J, Carbone J, Navarro J, Rodríguez J, Rodríguez-Sainz C, Fernández-Cruz E. Sublingual therapeutic immunization with a polyvalent bacterial preparation in patients with recurrent respiratory infections: immunomodulatory effect on antigen-specific memory CD4+ T cells and impact on clinical outcome. Clin Exp Immunol. 2011 Apr; 164(1):100-7.

11.  Arda B, Durusoy R, Yamazhan T, Sipahi OR, Taþbakan M, Pullukçu H, Erdem E, Ulusoy S. Did the pandemic have an impact on influenza vaccination attitude? A survey among health care workers. BMC Infect Dis. 2011 Apr 7; 11:87.

12.  Ashton R, Young SH. Immunization from a photographic perspective: the 1961 polio trial in Nova Scotia. CMAJ. 2011 Apr 19; 183(7):E356-60.

13.  Baba K, Okuno Y, Tanaka-Taya K, Okabe N. Immunization coverage and natural infection rates of vaccine-preventable diseases among children by questionnaire survey in 2005 in Japan. Vaccine. 2011 Apr 5; 29(16):3089-92.

14.  Baek JY, Ko KS, Kim SH, Kang CI, Chung DR, Peck KR, Song JH. Comparison of genotypes of Streptococcus pneumoniae serotypes 6A and 6B before and after the introduction of PCV7 vaccination in Korea. Diagn Microbiol Infect Dis. 2011 Apr; 69(4):370-5.

15.  Bardenheier B, Shefer A, Ahmed F, Remsburg R, Rowland Hogue CJ, Gravenstein S. Do vaccination strategies implemented by nursing homes narrow the racial gap in receipt of influenza vaccination in the United States? J Am Geriatr Soc. 2011 Apr; 59(4):687-93.

16.  Bardenheier B, Wortley P, Ahmed F, Gravenstein S, Hogue CJ. Racial inequities in receipt of influenza vaccination among long-term care residents within and between facilities in Michigan. Med Care. 2011 Apr; 49(4):371-7.

17.  Biai S, Rodrigues A, Nielsen J, Sodemann M, Aaby P. Vaccination status and sequence of vaccinations as risk factors for hospitalisation among outpatients in a high mortality country. Vaccine. 2011 May 9; 29(20):3662-9.

18.  Bray M. Understanding smallpox vaccination. J Infect Dis. 2011 Apr; 203(8):1037-9.

19.  Bucasas KL, Franco LM, Shaw CA, Bray MS, Wells JM, Niño D, Arden N, Quarles JM, Couch RB, Belmont JW. Early patterns of gene expression correlate with the humoral immune response to influenza vaccination in humans. J Infect Dis. 2011 Apr 1; 203(7):921-9.

20.  Buttery JP, Danchin MH, Lee KJ, Carlin JB, McIntyre PB, Elliott EJ, Booy R, Bines JE; for the PAEDS/APSU Study Group. Intussusception following rotavirus vaccine administration: Post-marketing surveillance in the National Immunization Program in Australia. Vaccine. 2011 Apr 5; 29(16):3061-3066.

21.  Chen SC, Hawkins G, Aspinall E, Patel N. Factors influencing uptake of influenza A (H1N1) vaccine amongst healthcare workers in a regional pediatric centre: Lessons for improving vaccination rates. Vaccine. 2011 Apr 25. [Epub ahead of print].

22.  Chen WH, Cross AS, Edelman R, Sztein MB, Blackwelder WC, Pasetti MF. Antibody and Th1-type cell-mediated immune responses in elderly and young adults immunized with the standard or a high dose influenza vaccine. Vaccine. 2011 Apr 5; 29(16):2865-73.

23.  Chesser A, Paschal A, Hart T, Jones J, Williams KS, Ahlers-Schmidt CR. Communication Practices for Pediatric Immunization Information: Physician Perceptions of Parent Health Literacy Skills. Clin Pediatr (Phila). 2011 Apr 27.[Epub ahead of print].

24.  Chovancova Z, Vlkova M, Litzman J, Lokaj J, Thon V. Antibody forming cells and plasmablasts in peripheral blood in CVID patients after vaccination. Vaccine. 2011 Apr 5. [Epub ahead of print].

25.  Cohen R, Levy C, Bonnet E, Thollot F, Boucherat M, Fritzell B, Derkx V, Bingen E, Varon E. Risk Factors for Serotype 19A Carriage After Introduction of 7-valent Pneumococcal Vaccination. BMC Infect Dis. 2011 Apr 18; 11(1):95. [Epub ahead of print].

26.  Counts MM, Rehm SJ. Pneumococcal vaccination: Shifting attention to a neglected public health weapon. J Am Acad Nurse Pract. 2011 May; 23(5):223-5.

27.  Crespo I, Cardeñosa N, Godoy P, Carmona G, Sala MR, Barrabeig I, Alvarez J, Minguel S, Camps N, Caylà J, Domínguez A. Epidemiology of pertussis in a country  with high vaccination coverage. Vaccine. 2011 Apr 11. [Epub ahead of print].

28.  Cristiani C, Tuccori M, Pepe P, Sarteschi A, Maddalo F, Simonini G, Michi P, Consigli V, Fornai M, Antonioli L, Blandizzi C. Safety of MF-59 adjuvanted vaccine for pandemic influenza: Results of the vaccination campaign in an Italian health district. Vaccine. 2011 Apr 18; 29(18):3443-8.

29.  Debruyn JC, Hilsden R, Fonseca K, Russell ML, Kaplan GG, Vanderkooi O, Wrobel I. Immunogenicity and safety of influenza vaccination in children with inflammatory bowel disease. Inflamm Bowel Dis. 2011 Apr 6. [Epub ahead of print].

30.  Dell'era L, Esposito S, Corona F, Principi N. Vaccination of children and adolescents with rheumatic diseases. Rheumatology (Oxford). 2011 Apr 10. [Epub ahead of print].

31.  Diamond MR, O'Brien-Malone A. Vaccination, consent and multidose vials. Med J Aust. 2011 Apr 18; 194(8):414-6.

32.  do Carmo GM, Yen C, Cortes J, Siqueira AA, de Oliveira WK, Cortez-Escalante JJ, Lopman B, Flannery B, de Oliveira LH, Hage Carmo E, Patel M. Decline in diarrhea mortality and admissions after routine childhood rotavirus immunization  in Brazil: a time-series analysis. PLoS Med. 2011 Apr; 8(4):e1001024.

33.  Dubé E, Gilca V, Sauvageau C, Bradet R, Lavoie F, Boulianne N, Boucher FD, Bettinger JA, McNeil S, Gemmill I. Acute otitis media and its prevention by immunization: A survey of Canadian paediatricians' knowledge, attitudes and beliefs. Hum Vaccin. 2011 Apr 1; 7(4). [Epub ahead of print].

34.  Dubé E, Gilca V, Sauvageau C, Bradet R, Bettinger JA, Boulianne N, Boucher FD, McNeil S, Gemmill I, Lavoie F. Canadian paediatricians' opinions on rotavirus vaccination. Vaccine. 2011 Apr 12; 29(17):3177-82.

35.  Durand C, Flament E. [Pertussis vaccination for parents: Proposal and evaluation of two professional practices in a maternity hospital.]. Arch Pediatr. 2011 Apr; 18(4):362-369.

36.  El-Zein M, Parent MÉ, Rousseau MC. Comments on a recent meta-analysis: BCG vaccination and allergic conditions. J Allergy Clin Immunol. 2011 Apr; 127(4):1081.

37.  Elzen WP, Vossen AC, Cools HJ, Westendorp RG, Kroes AC, Gussekloo J. Cytomegalovirus infection and responsiveness to influenza vaccination in elderly  residents of long-term care facilities. Vaccine. 2011 Apr 14. [Epub ahead of print].

38.  Eneslätt K, Rietz C, Rydén P, Stöven S, House RV, Wolfraim LA, Tärnvik A, Sjöstedt A. Persistence of cell-mediated immunity three decades after vaccination with the live vaccine strain of Francisella tularensis. Eur J Immunol. 2011 Apr; 41(4):974-80.

39.  Fadnes LT, Nankabirwa V, Sommerfelt H, Tylleskär T, Tumwine JK, Engebretsen IM; for the PROMISE-EBF Study Group. Is vaccination coverage a good indicator of  age-appropriate vaccination? A prospective study from Uganda. Vaccine. 2011 Apr 27; 29(19):3564-3570.

40.  Franks I. Transplantation: Vaccinating transplant patients. Nat Rev Gastroenterol Hepatol. 2011 Apr 5. [Epub ahead of print].

41.  Gagneur A, Nowak E, Lemaitre T, Segura JF, Delaperrière N, Abalea L, Poulhazan E, Jossens A, Auzanneau L, Tran A, Payan C, Jay N, de Parscau L, Oger E; The IVANHOE investigators. Impact of rotavirus vaccination on hospitalizations for rotavirus diarrhea: The IVANHOE study. Vaccine. 2011 May 12; 29(21):3753-3759.

42.  Gall SA, Myers J, Pichichero M. Maternal immunization with tetanus-diphtheria-pertussis vaccine: effect on maternal and neonatal serum antibody levels. Am J Obstet Gynecol. 2011 Apr; 204(4):334.e1-5.

43.  García-Basteiro AL, Bayas JM, Campins M, Torres M, Serra C, Varela P, Barbé E, Vidal J; por el Grupo de Estudio de la Varicela en Hospitales de Cataluña. [Susceptibility to varicella among health care workers. Acceptability and response to vaccination.]. Med Clin (Barc). 2011 Apr 25. [Epub ahead of print].

44.  Gautret P, Tantawichien T, Hai VV, Piyaphanee W. Determinants of pre-exposure rabies vaccination among foreign backpackers in Bangkok, Thailand. Vaccine. 2011 Apr 13. [Epub ahead of print].

45.  Gil-Prieto R. [Acceptance of varicella vaccination in susceptible health personnel.]. Med Clin (Barc). 2011 Apr 19. [Epub ahead of print].

46.  Gilles I, Bangerter A, Clémence A, Green EG, Krings F, Staerklé C, Wagner-Egger P. Trust in medical organizations predicts pandemic (H1N1) 2009 vaccination behavior and perceived efficacy of protection measures in the Swiss public. Eur J Epidemiol. 2011 Mar; 26(3):203-10.

47.  Giufrè M, Cardines R, Caporali MG, Accogli M, D'Ancona F, Cerquetti M. Ten years of Hib vaccination in Italy: Prevalence of non-encapsulated Haemophilus influenzae among invasive isolates and the possible impact on antibiotic resistance. Vaccine. 2011 Apr 1. [Epub ahead of print].

48.  Grau S, Luque S, Pi-Sunyer J, Horcajada JP, Villar R, Berenguer N, Urbina O,  Serra C. [Low adherence to 2009 pandemic influenza A(H1N1)vaccination program among health care workers of a medical centre during the pandemic phase.]. Enferm Infecc Microbiol Clin. 2011 Apr; 29(4):269-275.

49.  Greenland K, Rondy M, Chevez A, Sadozai N, Gasasira A, Abanida EA, Pate MA, Ronveaux O, Okayasu H, Pedalino B, Pezzoli L. Clustered lot quality assurance sampling: a pragmatic tool for timely assessment of vaccination coverage. Trop Med Int Health. 2011 Apr 11.

50.  Gupta PN, Vyas SP. Colloidal carrier systems for transcutaneous immunization. Curr Drug Targets. 2011 Apr 1; 12(4):579-97.

51.  Halperin BA, Halperin SA. The reemergence of pertussis and infant deaths: is it time to immunize pregnant women? Future Microbiol. 2011 Apr; 6:367-9.

52.  Hanquet G, Lernout T, Vergison A, Verhaegen J, Kissling E, Tuerlinckx D, Malfroot A, Swennen B, Sabbe M; for the Belgian IPD Scientific Committee. Impact of conjugate 7-valent vaccination in Belgium: Addressing methodological challenges. Vaccine. 2011 Apr 5; 29(16):2856-2864.

53.  Harris K, Maurer J, Black C, Euler G, Kadiyala S. Workplace efforts to promote influenza vaccination among healthcare personnel and their association with uptake during the 2009 pandemic influenza A (H1N1). Vaccine. 2011 Apr 5; 29(16):2978-85.

54.  Helms C, Polgreen P, Polgreen L, Evans T, Roberts LL, Clabaugh G, Quinlisk P. Voluntary reporting of employee influenza vaccination rates by acute care hospitals in Iowa: The impact of a four year provider-based statewide performance improvement project. Vaccine. 2011 Apr 18; 29(18):3483-8.

55.  Herzog SA, Paul M, Held L. Heterogeneity in vaccination coverage explains the size and occurrence of measles epidemics in German surveillance data. Epidemiol Infect. 2011 Apr; 139(4):505-15.

56.  Holtfreter S, Jursa-Kulesza J, Masiuk H, Verkaik NJ, de Vogel C, Kolata J, Nowosiad M, Steil L, van Wamel W, van Belkum A, Völker U, Giedrys-Kalemba S, Bröker BM. Antibody responses in furunculosis patients vaccinated with autologous formalin-killed Staphylococcus aureus. Eur J Clin Microbiol Infect Dis. 2011 Apr 22. [Epub ahead of print].

57.  Hopman CE, Riphagen-Dalhuisen J, Looijmans-van den Akker I, Frijstein G, Van der Geest-Blankert AD, Danhof-Pont MB, De Jager HJ, Bos AA, Smeets E, De Vries MJ, Gallee PM, Lenderink AF, Hak E. Determination of factors required to increase uptake of influenza vaccination among hospital-based healthcare workers. J Hosp Infect. 2011 Apr; 77(4):327-31.

58.  Hubble MW, Zontek TL, Richards ME. Predictors of influenza vaccination among  emergency medical services personnel. Prehosp Emerg Care. 2011 Apr-Jun; 15(2):175-83.

59.  Hukic M, Hübschen JM, Seremet M, Salimovic-Besic I, Mulaomerovic M, Mehinovic N, Karakas S, Charpentier E, Muller CP. An outbreak of rubella in the Federation of Bosnia and Herzegovina between December 2009 and May 2010 indicates failure to vaccinate during wartime (1992-1995). Epidemiol Infect. 2011 Apr 28:1-7. [Epub ahead of print].

60.  Hurst FP, Lee JJ, Jindal RM, Agodoa LY, Abbott KC. Outcomes Associated with Influenza Vaccination in the First Year after Kidney Transplantation. Clin J Am Soc Nephrol. 2011 Apr 28. [Epub ahead of print].

61.  Jacobs S, Warman A, Richardson R, Yacoub W, Lau A, Whittaker D, Cockburn S, Verma G, Boffa J, Tyrrell G, Kunimoto D, Manfreda J, Langlois-Klassen D, Long R.  The Tuberculin Skin Test Is Unreliable in School Children BCG-vaccinated in Infancy and at Low Risk of Tuberculosis Infection. Pediatr Infect Dis J. 2011 Apr 11. [Epub ahead of print].

62.  Jhanji V, Naithani P, Lamoureux E, Agarwal T, Sharma N, Vajpayee RB. Immunization and Nutritional Profile of Cases with Atraumatic Microbial Keratitis in Preschool Age Group. Am J Ophthalmol. 2011 Apr 4. [Epub ahead of print].

63.  Jiménez-García R, Rodríguez-Rieiro C, Hernández-Barrera V, Andres AL, Cuadrado AR, Laso AR, Carrasco-Garrido P. Effectiveness of age-based strategies to increase influenza vaccination coverage among high risk subjects in Madrid (Spain). Vaccine. 2011 Apr 5; 29(16):2840-5.

64.  Kaiser HE, Barnett DJ, Hayanga AJ, Brown ME, Filak AT. Medical Students' Participation in the 2009 Novel H1N1 Influenza Vaccination Administration: Policy Alternatives for Effective Student Utilization to Enhance Surge Capacity in Disasters. Disaster Med Public Health Prep. 2011 Apr 11. [Epub ahead of print].

65.  Karanfil LV, Bahner J, Hovatter J, Thomas WL. Championing Patient Safety through Mandatory Influenza Vaccination for All Healthcare Personnel and Affiliated Physicians. Infect Control Hosp Epidemiol. 2011 Apr; 32(4):375-9.

66.  Kardas P, Zasowska A, Dec J, Stachurska M. Reasons for low influenza vaccination coverage: cross-sectional survey in Poland. Croat Med J. 2011 Apr 15; 52(2):126-33.

67.  Kim YC, Jarrahian C, Zehrung D, Mitragotri S, Prausnitz MR. Delivery Systems for Intradermal Vaccination. Curr Top Microbiol Immunol. 2011 Apr 7. [Epub ahead of print].

68.  Klein NP, Aukes L, Lee J, Fireman B, Shapira SK, Slade B, Baxter R, Summar M. Evaluation of Immunization Rates and Safety Among Children With Inborn Errors of Metabolism. Pediatrics. 2011 Apr 11. [Epub ahead of print].

69.  Koppi S, Faé P, Hartmann G, Höftberger R, Holzmann H. [Fatal outcome of tick-borne encephalitis despite complete active vaccination.]. Nervenarzt. 2011 Apr; 82(4):506-508.

70.  Kuehn BM. 10-year national vaccine plan aims to harness new technology, enhance safety. JAMA. 2011 Apr 13; 305(14):1399-400.

71.  Kweon MN. Sublingual mucosa: A new vaccination route for systemic and mucosal immunity. Cytokine. 2011 Apr; 54(1):1-5.

72.  Lang PO, Govind S, Michel JP, Aspinall R, Mitchell WA. Immunosenescence: Implications for vaccination programmes in adults. Maturitas. 2011 Apr; 68(4):322-30.

73.  Langley JM, Naus M. Immunization: a global challenge for the 21st Century. Expert Rev Vaccines. 2011 Apr; 10(4):429-31.

74.  Li J, Yang Y. SIR-SVS epidemic models with continuous and impulsive vaccination strategies. J Theor Biol. 2011 Apr 5. [Epub ahead of print].

75.  Ljungman P, Small TN. Vaccination of SCT recipients. Bone Marrow Transplant.  2011 Apr; 46(4):621.

76.  Mahut B, Refabert L, Marchac V, Iniguez JL, Aubertin G, Tamalet A, Lebras MN, Troadec C, Chatellier G, Delclaux C. Influenza-like illness responsible for severe exacerbations in asthmatic children during H1N1 pandemic: a survey before vaccination. J Asthma. 2011 Apr; 48(3):224-7.

77.  Marzo Sola ME, Vaquero Garrido M, Bártulos Iglesias M, Gil Pujades A. Facial  variant of Guillain-Barré Syndrome in a patient, days after being vaccinated for  influenza A. Neurologia. 2011 Apr; 26(3):186-188.

78.  Meier S, Bel M, L'huillier A, Crisinel PA, Combescure C, Kaiser L, Grillet S, Pósfay-Barbe K, Siegrist CA; with the H1N1 Epidemiology Study Group of Geneva. Antibody responses to natural influenza A/H1N1/09 disease or following immunization with adjuvanted vaccines, in immunocompetent and immunocompromised children. Vaccine. 2011 Apr 27; 29(19):3548-57.

79.  Michaelidis CI, Zimmerman RK, Nowalk MP, Smith KJ. Estimating the cost-effectiveness of a national program to eliminate disparities in influenza vaccination rates among elderly minority groups. Vaccine. 2011 Apr 27; 29(19):3525-30.

80.  Middleman AB, Tung JS. School-located immunization programs: Do parental preferences predict behavior? Vaccine. 2011 Apr 27; 29(19):3513-6.

81.  Miller EK, Dumitrescu L, Cupp C, Dorris S, Taylor S, Sparks R, Fawkes D, Frontiero V, Rezendes AM, Marchant C, Edwards KM, Crawford DC. Atopy history and the genomics of wheezing after influenza vaccination in children 6-59 months of age. Vaccine. 2011 Apr 18; 29(18):3431-7.

82.  Mogasale V, Barendregt J. Cost-effectiveness of influenza vaccination of people aged 50-64 years in Australia: results are inconclusive. Aust N Z J Public Health. 2011 Apr; 35(2):180-6.

83.  Mortimer PP. The diphtheria vaccine debacle of 1940 that ushered in comprehensive childhood immunization in the United Kingdom. Epidemiol Infect. 2011 Apr; 139(4):487-93.

84.  Nishiura H, Oshitani H. Effects of Vaccination against Pandemic (H1N1) 2009 among Japanese Children. Emerg Infect Dis. 2011 Apr; 17(4):746-7.

85.  Oria PA, Matini W, Nelligan I, Emukule G, Scherzer M, Oyier B, Ochieng HN, Hooper L, Kanyuga A, Muthoka P, Morales KF, Nzioka C, Breiman RF, Katz MA. Are Kenyan healthcare workers willing to receive the pandemic influenza vaccine? Results from a cross-sectional survey of healthcare workers in Kenya about knowledge, attitudes and practices concerning infection with and vaccination against 2009 pandemic influenza A (H1N1), 2010. Vaccine. 2011 Apr 27; 29(19):3617-22.

86.  Ota MO, Akinsola A, Townend J, Antonio M, Enwere G, Nsekpong D, Bojang A, Saaka M, Burton RL, Zaman A, Goldblatt D, Adegbola RA. The immunogenicity and impact on nasopharyngeal carriage of fewer doses of conjugate pneumococcal vaccine immunization schedule. Vaccine. 2011 Apr 5; 29(16):2999-3007.

87.  Parry HM, Damery S, Fergusson A, Draper H, Bion J, Low AE. Pandemic influenza A (H1N1) 2009 in a critical care and theatre setting: beliefs and attitudes towards staff vaccination. J Hosp Infect. 2011 Apr 8. [Epub ahead of print].

88.  Pati S, Feemster KA, Mohamad Z, Fiks A, Grundmeier R, Cnaan A. Maternal health literacy and late initiation of immunizations among an inner-city birth cohort. Matern Child Health J. 2011 Apr; 15(3):386-94.

89.  Pauwels C, Bulai Livideanu C, Maza A, Lamant L, Paul C. Cytophagic Histiocytic Panniculitis after H1N1 Vaccination: A Case Report and Review of the Cutaneous Side Effects of Influenza Vaccines. Dermatology. 2011 Apr 13. [Epub ahead of print].

90.  Quaiyum MA, Gazi R, Khan AI, Uddin J, Islam M, Ahmed F, Saha NC. Programmatic aspects of dropouts in child vaccination in Bangladesh: findings from a prospective study. Asia Pac J Public Health. 2011 Apr; 23(2):141-50.

91.  Ratzan SC. A new shot for success-immunization and vaccine preparedness. J Health Commun. 2011 Apr; 16(4):341-2.

92.  Reluga TC, Galvani AP. A general approach for population games with application to vaccination. Math Biosci. 2011 Apr; 230(2):67-78.

93.  Rurik I, Langmar Z, Marton H, Kovacs E, Szigethy E, Ilyes I. Knowledge, motivation, and attitudes of Hungarian family physicians toward pandemic influenza vaccination in the 2009/10 influenza season: questionnaire study. Croat Med J. 2011 Apr 15; 52(2):134-40.

94.  Scott LJ. Spotlight on Tdap₅ vaccine (Covaxis®) as a single-booster immunization for the prevention of tetanus, diphtheria, and pertussis: in children (aged ≥4 years), adolescents, and adults. Paediatr Drugs. 2011 Apr 1; 13(2):133-5.

95.  Seidel A, Smith D, Yung E, Aquino L, Srivastava T, Pullarkat V, Spielberger  R, Forman SJ, Diamond DJ. CD154 expression is associated with neutralizing antibody titer levels postinfluenza vaccination in stem cell transplant patients and healthy adults. Biol Blood Marrow Transplant. 2011 Apr; 17(4):524-33.

96.  Shu M, Liu Q, Wang J, Ao R, Yang C, Fang G, Wan C, Guo W. Measles vaccine adverse events reported in the mass vaccination campaign of Sichuan province, China from 2007 to 2008. Vaccine. 2011 Apr 18; 29(18):3507-10.

97.  Solén MG, Melhus A, Hermansson A. Pneumococcal vaccination in children at risk of developing recurrent acute otitis media - a randomized study. Acta Paediatr. 2011 Apr 22. [Epub ahead of print].

98.  Spijkerman J, van Gils EJ, Veenhoven RH, Hak E, Yzerman EP, van der Ende A,  Wijmenga-Monsuur AJ, van den Dobbelsteen GP, Sanders EA. Carriage of Streptococcus pneumoniae 3 Years after Start of Vaccination Program, the Netherlands. Emerg Infect Dis. 2011 Apr; 17(4):584-591.

99.  Steelfisher GK, Blendon RJ, Bekheit MM, Mitchell EW, Williams J, Lubell K, Peugh J, Disogra CA. Novel pandemic A (H1N1) influenza vaccination among pregnant women: motivators and barriers. Am J Obstet Gynecol. 2011 Apr 12. [Epub ahead of print].

100. Stockwell MS, Rosenthal SL, Sturm LA, Mays RM, Bair RM, Zimet GD. The effects of vaccine characteristics on adult women's attitudes about vaccination: A conjoint analysis study. Vaccine. 2011 Apr 25. [Epub ahead of print].

101. Sutherland JN, Chang C, Yoder SM, Rock MT, Maynard JA. Antibodies recognizing protective pertussis toxin epitopes are preferentially elicited by natural infection versus acellular immunization. Clin Vaccine Immunol. 2011 Apr 20. [Epub ahead of print].

102. Tang CW, Huang SH, Weng KP, Ger LP, Hsieh KS. Parents' views about the vaccination program in Taiwan. Pediatr Neonatol. 2011 Apr; 52(2):98-102.

103. Tanguy M, Boyeau C, Pean S, Marijon E, Delhumeau A, Fanello S. Acceptance of seasonal and pandemic a (H1N1) 2009 influenza vaccination by healthcare workers in a French Teaching Hospital. Vaccine. 2011 Apr 14. [Epub ahead of print].

104. Tate JE, Kisakye A, Mugyenyi P, Kizza D, Odiit A, Braka F. Projected health  benefits and costs of pneumococcal and rotavirus vaccination in Uganda. Vaccine.  2011 Apr 12; 29(17):3329-34.

105. Toback SL, Carr W, Hackell J, Bhatt P, Ryan A, Ambrose CS. Influenza vaccination of parents and guardians by US pediatricians. Hum Vaccin. 2011 Apr 1; 7(4). [Epub ahead of print].

106. Toback SL, Herley J, Edelman L, Ambrose CS. Trends in US pediatric influenza vaccination from 2006 to 2010 among children with private insurance. Vaccine. 2011 Apr 14. [Epub ahead of print].

107. van Assen S, Elkayam O, Agmon-Levin N, Cervera R, Doran MF, Dougados M, Emery P, Geborek P, Ioannidis JP, Jayne DR, Kallenberg CG, Müller-Ladner U, Shoenfeld Y, Stojanovich L, Valesini G, Wulffraat NM, Bijl M. Vaccination in adult patients with auto-immune inflammatory rheumatic diseases: A systematic literature review for the European League Against Rheumatism evidence-based recommendations for vaccination in adult patients with auto-immune inflammatory rheumatic diseases. Autoimmun Rev. 2011 Apr; 10(6):341-52.

108. van den Bergh MR, Spijkerman J, François N, Swinnen K, Borys D, Schuerman L, Veenhoven RH, Sanders EA. Immunogenicity, Safety, and Reactogenicity of the 10 Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine and DTPa-IPV-Hib When Coadministered as a 3-Dose Primary Vaccination Schedule in the Netherlands: A Randomized Controlled Trial. Pediatr Infect Dis J. 2011 Apr 11. [Epub ahead of print].

109. Virgili G, Turchetti G, Gusinu R, Gensini GF. Commentary on: Economic evaluation of human papilloma virus vaccination in the European Union: a critical review. Intern Emerg Med. 2011 Apr; 6(2):157-8.

110. Visser LG. TNF-α Antagonists and Immunization. Curr Infect Dis Rep. 2011 Apr 1. [Epub ahead of print].

111. Walter D, Böhmer MM, Heiden MA, Reiter S, Krause G, Wichmann O. Monitoring pandemic influenza A(H1N1) vaccination coverage in Germany 2009/10 - Results from thirteen consecutive cross-sectional surveys. Vaccine. 2011 Apr 2. [Epub ahead of print].

112. Webb L, Petersen M, Boden S, Labelle V, Bird JA, Howell D, Burks AW, Laubach S. Single-dose influenza vaccination of patients with egg allergy in a multicenter study. J Allergy Clin Immunol. 2011 Apr 1. [Epub ahead of print].

113. Weinberger DM, Malley R, Lipsitch M. Serotype replacement in disease after pneumococcal vaccination. Lancet. 2011 Apr 12. [Epub ahead of print].

114. Wilson K, Hawken S, Potter BK, Chakraborty P, Kwong J, Crowcroft N, Rothwell D, Manuel D. Patterns of emergency room visits, admissions and death following recommended pediatric vaccinations-A population based study of 969,519 vaccination events. Vaccine. 2011 May 12; 29(21):3746-52.

115. Yalçýn SS, Engür-Karasimav D, Alehan D, Yurdakök K, Ozkutlu S, Coþkun T. Zinc supplementation and TNF-α levels in vaccinated cardiac patients. J Trace Elem Med Biol. 2011 Apr 21. [Epub ahead of print].

116. Youngster I, Kozer E, Lazarovitch Z, Broide E, Goldman M. Probiotics and the immunological response to infant vaccinations: a prospective, placebo controlled  pilot study. Arch Dis Child. 2011 Apr; 96(4):345-9.

117. Yung CF, Andrews N, Bukasa A, Brown KE, Ramsay M. Mumps complications and effects of mumps vaccination, England and Wales, 2002-2006. Emerg Infect Dis. 2011 Apr; 17(4):661-7.

118. Zhang J, While AE, Norman IJ. Nurses' knowledge and risk perception towards seasonal influenza and vaccination and their vaccination behaviours: A cross-sectional survey. Int J Nurs Stud. 2011 Apr 5. [Epub ahead of print].